David Foureau, Associate Professor, Research Group Director at Levine Cancer Institute Atrium Health, posted the following on LinkedIn:
“My deepest gratitude to the Purple Promise Foundation for their continued support of our melanoma immunotherapy research program. This $100,000 grant will be used to study strategies to redirect immunotherapy for recurring melanoma patients.”
Source: David Foureau/LinkedIn